Aleve Analgesic Products Recalled Due to Improper Storage Temperature Conditions
Family Dollar is recalling three Aleve products due to storage temperature deviations. Products were held outside appropriate conditions from April 30 through June 10, 2022.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses, injuries, or deaths. The hazard is a manufacturing storage compliance violation creating theoretical risk to product quality, but without documented adverse effects.
Plain-English summary
Family Dollar Stores, LLC is recalling specific Aleve products due to improper storage conditions. The products were held outside appropriate temperature ranges during distribution, which constitutes a manufacturing compliance violation (CGMP deviation).
The recall affects three Aleve products: Aleve Analgesic Back Muscle 24 ct (SKU 999787), Aleve PM Caplets 20 ct (SKU 900442), and Aleve Caplet 50 ct (SKU 916980). These products were distributed to specific Family Dollar Stores between April 30, 2022 and June 10, 2022.
Consumers with any of the recalled SKUs should not use them. Return the products to the Family Dollar Store where purchased for a refund or contact the recalling firm for further instructions.
The recalled product
- Product
- ALEVE ANALGESIC BACK MUSCLE 24 CT SKU 999787 ALEVE PM CAPLETS 20 CT SKU 900442 ALEVE CAPLET 50 CT SKU 916980 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Hazard
- improper-storage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- SKUs: 999787
- 900442
- 916980
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27